Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: After completing the course of Paxlovid and being 10 days post initial symptoms I tested positive again on a rapid test after testing negative for 4 days prior; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (After completing the course of Paxlovid and being 10 days post initial symptoms I tested positive again on a rapid test after testing negative for 4 days prior) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939903) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Name of Drug as Reported-No). Concomitant products included ATORVASTATIN from an unknown date to 17-May-2022 for an unknown indication.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2022, the patient experienced COVID-19 (After completing the course of Paxlovid and being 10 days post initial symptoms I tested positive again on a rapid test after testing negative for 4 days prior). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 18-May-2022 to 23-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (After completing the course of Paxlovid and being 10 days post initial symptoms I tested positive again on a rapid test after testing negative for 4 days prior) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: negative (Negative) Negative and positive (Positive) Positive.         The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient had previously received a COVID-19 Vaccine.   It was reported that after completing the course of Paxlovid and being 10 days post initial symptoms patient tested positive again on a rapid test after testing negative for 4 days prior. Company comment: This is a spontaneous case concerning a 43-year-old male patient with no relevant medical history reported, who experienced the non-serious, unexpected AESI event of COVID-19, which occurred on an unknown date after the third dose of mRNA-1273, thus latency between vaccination and the event cannot be assessed. It was reported that after completing the course of Paxlovid and being 10 days post initial symptoms patient tested positive again on a rapid test after testing negative for 4 days prior. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 43-year-old male patient with no relevant medical history reported, who experienced the non-serious, unexpected AESI event of COVID-19, which occurred on an unknown date after the third dose of mRNA-1273, thus latency between vaccination and the event cannot be assessed. It was reported that after completing the course of Paxlovid and being 10 days post initial symptoms patient tested positive again on a rapid test after testing negative for 4 days prior. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.